Ecnoglutide yields superior, sustained reduction in body weight: Study
For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon-like peptide 1 receptor agonist known as ecnoglutide yields a superior and sustained reduction in body weight versus placebo
Source: Medical Xpress